Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 5
2008 2
2009 5
2010 6
2011 2
2012 2
2013 1
2014 3
2015 3
2016 2
2017 1
2018 4
2019 1
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death.
Pozzi C, Cuomo A, Spadoni I, Magni E, Silvola A, Conte A, Sigismund S, Ravenda PS, Bonaldi T, Zampino MG, Cancelliere C, Di Fiore PP, Bardelli A, Penna G, Rescigno M. Pozzi C, et al. Among authors: Zampino MG. Nat Med. 2016 Jun;22(6):624-31. doi: 10.1038/nm.4078. Epub 2016 May 2. Nat Med. 2016. PMID: 27135741
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
Sobrero A, Lonardi S, Rosati G, Di Bartolomeo M, Ronzoni M, Pella N, Scartozzi M, Banzi M, Zampino MG, Pasini F, Marchetti P, Cantore M, Zaniboni A, Rimassa L, Ciuffreda L, Ferrari D, Zagonel V, Maiello E, Barni S, Rulli E, Labianca R; TOSCA Investigators. Sobrero A, et al. Among authors: Zampino MG. J Clin Oncol. 2018 May 20;36(15):1478-1485. doi: 10.1200/JCO.2017.76.2187. Epub 2018 Apr 5. J Clin Oncol. 2018. PMID: 29620994 Clinical Trial.
Phase III study with FOLFIRIĀ + cetuximab versus FOLFIRIĀ + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Pinto C, Normanno N, Orlandi A, Fenizia F, Damato A, Maiello E, Tamburini E, Di Costanzo F, Tonini G, Bilancia D, Corsi D, Pisconti S, Ferrau F, Gori S, Daniele B, Zaniboni A, Soto Parra H, Frassinetti GL, Iaffaioli RV, Cassata A, Zampino MG, Repetto L, Calegari MA, Barone C; all the investigators of ERMES study group.. Pinto C, et al. Among authors: Zampino MG. Future Oncol. 2018 Jun;14(14):1339-1346. doi: 10.2217/fon-2017-0592. Epub 2018 May 30. Future Oncol. 2018. PMID: 29846100 Clinical Trial.
Rectal cancer.
Zampino MG, Labianca R, Beretta G, Gatta G, Lorrizo K, Braud Fd Fd, Wils J. Zampino MG, et al. Crit Rev Oncol Hematol. 2004 Aug;51(2):121-43. doi: 10.1016/j.critrevonc.2004.03.004. Crit Rev Oncol Hematol. 2004. PMID: 15276176 Review.
Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
Mauri G, Varano GM, Della Vigna P, Bonomo G, Monfardini L, Zampino MG, Ravenda PS, Orsi F. Mauri G, et al. Among authors: Zampino MG. Cardiovasc Intervent Radiol. 2018 Nov;41(11):1708-1715. doi: 10.1007/s00270-018-2017-x. Epub 2018 Jun 27. Cardiovasc Intervent Radiol. 2018. PMID: 29951693
Rectal cancer.
Zampino MG, Labianca R, Beretta GD, Magni E, Gatta G, Leonardi MC, Chiappa A, Biffi R, de Braud F, Wils J. Zampino MG, et al. Crit Rev Oncol Hematol. 2009 May;70(2):160-82. doi: 10.1016/j.critrevonc.2008.10.010. Epub 2008 Dec 6. Crit Rev Oncol Hematol. 2009. PMID: 19059790
Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil?
Ravenda PS, Zampino MG, Fazio N, Barberis M, Bottiglieri L, Chiocca S. Ravenda PS, et al. Among authors: Zampino MG. Ecancermedicalscience. 2015 Apr 29;9:529. doi: 10.3332/ecancer.2015.529. eCollection 2015. Ecancermedicalscience. 2015. PMID: 25987898 Free PMC article.
36 results
Jump to page
Feedback